Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia is a common hair thinning condition linked to genetics and hormones.

Caffeine can potentially treat common hair loss by counteracting hair follicle shrinkage caused by hormones.

Androgenetic alopecia is more common in male Chinese adolescents and linked to rosacea, but doesn't affect quality of life.

Androgenetic alopecia is more common in Indian men than women, and family history is a strong risk factor.

The most common treatment for hair loss in the study was a 5% minoxidil solution, with women more likely to receive multiple medications. A significant number of patients also had hypothyroidism.

Men with common hair loss (AGA) are more likely to have metabolic syndrome, which increases heart disease risk. Early screening could help prevent heart disease. More research is needed to understand this relationship better.

Androgenetic alopecia is a common form of hair loss in both men and women.

Vertex accentuation is a common pattern in female hair loss.

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.

Androgenetic alopecia is a common type of hair loss in men and women, caused by a testosterone byproduct affecting hair follicles, with sensitivity determined by genetics.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Hair loss in men is common, treatable, but not curable.

Eczema and fungal infections are the most common skin problems in Japan, with different age groups and genders affected by various conditions.

"Male-pattern" hair loss is common in women, especially after menopause, and doesn't always mean there's a problem with hormone balance.

Hair loss in women is common, starts in late 20s, and affects 30% of women over 50.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

The study suggests smoking is common in HS patients but its role is unclear, and more research is needed to understand HS causes.

Minoxidil 2% and 5% are common treatments for female pattern hair loss, with other options including anti-androgens, oral contraceptives, and hair transplantation.

Non-motor symptoms in myasthenia gravis are common and need early diagnosis for better management.

Hair loss in secondary syphilis is more common than thought and can be reversed with antibiotics.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

The S100A4 protein is more common in psoriatic skin and could be a target for treating psoriasis.

Insulinomas and adrenocortical tumors are common in older ferrets, diagnosed with blood tests and ultrasounds, and treated with medications or surgery.

Skin reactions to antidepressants are common but usually not serious and can be treated.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

Hair loss from mood stabilizers is common but can be managed without stopping the medication.

Polycystic Ovary Syndrome (PCOS) is not very common among Iranian women, but it's important to prevent it because of the risk of heart disease and infertility.

Steroidogenic isoenzymes may help improve treatments for common hair loss.